Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic potential of enhancer of zeste homolog 2 in autoimmune diseases

21 Nov 2019

Abstract excerpt

Introduction: Autoimmune diseases (ADs) are idiopathic and heterogeneous disorders with contentious pathophysiology. Great strides have been made in epigenetics and its involvement in ADs. Zeste homolog 2 (EZH2) has sparked extensive interest because of its pleiotropic roles in distinct pathologic contexts.Areas covered: This review summarizes the epigenetic functions and the biological significance of EZH2 in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research
Share to IL-33, ST2, and ILC Pathways
Share to Immune Cell Function and Interaction

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31747802
DOI: 10.1080/14728222.2019.1696309

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic potential of enhancer of zeste homolog 2 in autoimmune diseasesPMID 31747802Read ↗

Emerging role of EZH2 in rheumatic diseases: A comprehensive reviewSemantic proximity Read ↗

ZEB1 promotes pathogenic Th1 and Th17 cell differentiation in multiple sclerosisSemantic proximity Read ↗

Global research hotspots and frontier trends of epigenetic modifications in autoimmune diseases: a bibliometric analysis from 2012 to 2022Semantic proximity Read ↗

The transcription factor Zeb2 drives formation of age-associated B cellsSemantic proximity Read ↗

Autoimmune disease: genetic susceptibility, environmental triggers, and immune dysregulation. Where can we develop therapies?Semantic proximity Read ↗

Critical roles of super-enhancers in the pathogenesis of autoimmune diseasesSemantic proximity Read ↗

Epstein-Barr virus nuclear antigen 2 (EBNA2) extensively rewires the human chromatin landscape at autoimmune risk lociSemantic proximity Read ↗

An update on the roles of transcription factor Ets1 in autoimmune diseasesSemantic proximity Read ↗

EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?Semantic proximity Read ↗

Multiomics characteristics and immunotherapeutic potential of EZH2 in pan-cancerSemantic proximity Read ↗

Exploring the Theranostic roles of miRNA and Epigenetics in Autoimmune Diseases - A Comprehensive ReviewSemantic proximity Read ↗

Novel insights of EZH2-mediated epigenetic modifications in degenerative musculoskeletal diseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.